Department news
Dr. Malany’s lab sends muscle tissue chips to the…
The tissue chips are part of a study examining muscle biology in microgravity.
Dr. Jay McLaughlin publishes in Molecular Brain
The article is titled, “Epigenetic signature of N-terminal acetyltransferases: a probable mediator of immune and neuropathogenesis in HIV infection.”
Dr. Jay McLaughlin publishes in Molecular Therapy…
The article is titled, “HIV-1 Tat and cocaine impact astrocytic energy reservoirs and epigenetic regulation by influencing the…
Department stats
$7.3 MILLION IN RESEARCH AWARDS, 2020-21
79 PUBLICATIONS IN 2020-21
11 TENURED AND TENURE-TRACK FACULTY
17 PH.D. STUDENTS
6 POSTDOCTORAL FELLOWS
Featured videos
UF COLLEGE OF PHARMACY
One degree, five concentrations
Discover the UF Pharmaceutical Sciences graduate program and learn about our comprehensive and collaborative research training among the five departments.
Play Video
Graduate education
Discover Greatness at the UF College of Pharmacy
Do you have the drive and determination to discover greatness? Whether in the lab, the clinic or through big data, you’re on a journey of asking questions – lots of them – to find answers.
Play Video
student profile
Sarthak Singhal and Yalun Tan
Graduate students Sarthak Singhal and Yalun Tan are young scientists studying how the brain functions from a cellular and behavioral level.
Play Video
College news
UF College of Pharmacy researchers aim to improve health equity in diabetes care
A four-year study aims to identify the patient groups who would benefit most from newer glucose-lowering drugs.
Dr. Hui Shao awarded $2.8 million grant to improve enrollment in the National Diabetes Prevention Program
The project aims to identify barriers and facilitators to the enrollment and completion of the National Diabetes Prevention Program and evaluate its long-term effectiveness and cost-effectiveness.
Dr. John Gums named interim dean of the UF College of Pharmacy
Dr. John Gums will help the college through the transition period until a new dean is named.
Dr. Hendrik Luesch and team awarded $8.8 million NIGMS grant to unlock limitations in natural product drug discovery research
The research will focus on marine organisms with exceptional biosynthetic potential, employing genomic and chemical approaches.
